|
業務類別
|
Medical Devices |
|
業務概覽
|
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market. |
| 公司地址
| 9201 West Broadway Avenue, Suite 650, Minneapolis, MN, USA, 55445 |
| 電話號碼
| +1 763 416-2840 |
| 傳真號碼
| +1 763 416-2841 |
| 公司網頁
| https://www.cvrx.com |
| 員工數量
| 223 |
| Mr. Jared Oasheim |
Chief Financial Officer and Principal Accounting Officer |
美元 414.00K |
13/02/2026 |
| Mr. Robert Allen John |
Chief Revenue Officer |
美元 241.15K |
23/04/2025 |
| Mr. Brent Binkowski |
Chief Operating Officer |
-- |
04/08/2025 |
| Mr. Paul Verrastro |
Chief Marketing and Strategy Officer |
-- |
23/04/2025 |
| Mr. Kevin Hykes, M.B.A. |
Director, President and Chief Executive Officer |
美元 569.95K |
13/02/2026 |
| Dr. Philip B. Adamson |
Chief Medical Officer |
-- |
23/04/2025 |
|
|
| Mr. Mitchell C. Hill |
Independent Director |
13/02/2026 |
| Mr. Kevin J. Ballinger |
Independent Director |
13/02/2026 |
| Ms. Martha Shadan |
Independent Director |
13/02/2026 |
| Mr. Kirk Nielsen |
Lead Independent Director |
13/02/2026 |
| Dr. Mudit K. Jain, PhD |
Independent Director |
13/02/2026 |
| Mr. Kevin Hykes, M.B.A. |
Director, President and Chief Executive Officer |
13/02/2026 |
| Mr. Joseph P. Slattery, C.P.A. |
Independent Director |
13/02/2026 |
|
|
|
|
